NPPA revises ceiling prices for over 900 drug formulations from April 1
With the changes, manufacturers will be allowed to increase the maximum retail price (MRP) of scheduled formulations on the ...
Medical Dialogues11d
Marksans Pharma arm gets marketing authorization for muscle relaxant tablets in UK
Mumbai: Marksans Pharma Limited's wholly owned subsidiary in the UK, Relonchem Limited receives marketing authorization for ...
Marksans Pharma up 3% as arm secures marketing authorisation for Baclofen
The northward move in Marksans Pharma came after the company's wholly-owned subsidiary, Relonchem, received Marketing ...
IndiaInfoline9d
Marksans Pharma’s Relonchem Gets UK MHRA Approval for Baclofen 10 mg
Baclofen is a muscle relaxant primarily prescribed to treat muscle spasms, cramping, and tightness associated with multiple ...
CNBCTV1811d
Marksans Pharma gains 3% as UK arm secures approval for muscle relaxant tablets
Shares of Marksans Pharma were trading higher in the afternoon session on Tuesday, up 2.14% at ₹207.2 per piece on the BSE at ...
Investing.com India11d
Marksans Pharma UK Subsidiary Secures MHRA Approval for Baclofen Tablets
Marksans Pharma, headquartered in Mumbai, specializes in research, manufacturing, and marketing of generic pharmaceutical ...
CNBCTV1810d
Marksans Pharma gains over 4% on Australian regulator’s nod for Goa facility
Marksans Pharma shares rose over 4% after its Goa plant secured Australian TGA approval for solid dosage forms. Its UK arm ...
Le News16d
The global brands artificially inflating their prices on Swiss versions of their websites
It is well known that the Swiss are overcharged for nearly everything. However, when products are being sent from a warehouse ...
Medscape4d
The Pathophysiological and Pharmacological Basis of Current Drug Treatment of Migraine Headache
100 mg tablets 5, 20 mg nasal spray, 4, 6 mg/0.5 ml cartridges; 6 mg/0.5 ml vials 50 or 100 mg p.o.; can be repeated after 2 h (max 200 mg/day), 5, 10 or 20 mg intranasally; can be repeated once ...